Condition: Neurodegenerative Diseases · Leukodystrophy · Ataxia · Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.
This description comes directly from the study's public registry record.
Jennifer L Keller, PT, MS · 443-923-2716 · keller@kennedykrieger.org
Amena Smith Fine, MD PhD · 443-923-3249 · finea@kennedykrieger.org
Always discuss trial participation with your own doctor first.
| Kennedy Krieger Institute | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05443906